Özet:

Purpose: Study the clinical and radiological effectiveness of botulinum toxin-A in children with cerebral palsy (SP) with adductor muscle spasticity. SP is a non-progressive disease of the central nervous system that leads to movement and posture disorders occurring in the intrauterine or early infant period. Tools and Methods: The work was designed retrospectively. The patient was diagnosed with regular BoNT-A injection for 1 year due to spastitis of the back adductor muscle. For clinical assessment, the knee distance, modified Asworth scale (MAS) and the crude motor function classification system (KMFSS) were recorded from patient files. Radiological assessment was determined by measuring the acetabular index (AI) and the collo-diafizer angle (KDA) in the anterior-posterior pelvis radiography. Results: The average age of 20 patients involved in the study (man: 12, girl: 8) was 84.8±20.9 months (minimum-maximum: 48-120 months). 7 patients were diplectic, 7 patients were quadriplectic and 6 patients mixed type SP. Patients' MAS and KMFSS scores decreased considerably in the 3rd and 12th months after the first injection (right p:0,007 left p:0,005 and p:0,002). Similarly, the distance between the knees increased gradually in the 3rd and 12th months (p<0,001). However, there was no significant improvement in AI and KDA in the radiological assessment (p>0,05). The result: In this study, it has been shown that in children with SP with adductor muscle spasticity, serial BoNT-A injection provides a clinical improvement and radiologically prevents progressive spinal dislocation.

Anahtar Kelimeler: